YIH
CLVS

Y-Intercept (HK)’s Clovis Oncology, Inc. CLVS Stock Holding History

Y-Intercept (HK)’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,630
Closed -$21K – 1371
2022
Q2 		$21K Buy
+11,630
New +$21K ﹤0.01% 791